Hit The Lab With These 17 Biotech ETFs
May 02, 2016 at 12:49 PM EDT
The time to buy, regardless of sector, is usually when a particular group falls out of favor, not when it has been bid higher by scores of investors. Some investors view that as the case with the broader healthcare group and biotechnology in particular. Multiple factors, including politics, are...